{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:58:24Z","timestamp":1790351904607,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018731","name":"Jiangsu Hengrui Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.tranon.2020.101004","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T06:47:26Z","timestamp":1609138046000},"page":"101004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer"],"prefix":"10.1016","volume":"14","author":[{"given":"Ningning","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiubao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanzhao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1700-9549","authenticated-orcid":false,"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2020.101004_bib0001","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/00365515609049266","article-title":"Demonstration of a new protein fraction in serum from the human fetus","volume":"8","author":"Bergstrand","year":"1956","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.tranon.2020.101004_bib0002","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000305717","article-title":"Hepatoid adenocarcinoma -review of the literature illustrated by a rare case originating in the peritoneal cavity","volume":"33","author":"Metzgeroth","year":"2010","journal-title":"Onkologie"},{"key":"10.1016\/j.tranon.2020.101004_bib0003","first-page":"504","article-title":"A case of primary lung cancer producing alpha-fetoprotein","volume":"11","author":"Yamagata","year":"2004","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.tranon.2020.101004_bib0004","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00535-006-1889-8","article-title":"Hepatoid carcinoma of the pancreas producing protein induced by vitamin K absence or antagonist II (PIVKA-II) and alpha-fetoprotein (AFP)","volume":"41","author":"Matsueda","year":"2006","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.tranon.2020.101004_bib0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/PAS.0b013e31823aafec","article-title":"Histologic and immunohistochemical analyses of \u03b1 -fetoprotein-producing cancer of the stomach","volume":"36","author":"Kinjo","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.tranon.2020.101004_bib0006","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12253-011-9424-5","article-title":"Hepatoid adenocarcinoma of the colon: what should we target?","volume":"18","author":"Cappetta","year":"2012","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.tranon.2020.101004_bib0007","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10147-008-0800-4","article-title":"Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman","volume":"14","author":"Isonishi","year":"2009","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2020.101004_bib0008","first-page":"1277","article-title":"Existence of alpha feto protein during gastric-origin secondary cancer of the liver","volume":"78","author":"Bourreille","year":"1970","journal-title":"Presse Med."},{"key":"10.1016\/j.tranon.2020.101004_bib0009","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/1097-0142(19850815)56:4<840::AID-CNCR2820560423>3.0.CO;2-E","article-title":"An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report","volume":"56","author":"Ishikura","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.tranon.2020.101004_bib0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jso.21624","article-title":"Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases","volume":"102","author":"Liu","year":"2010","journal-title":"J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2020.101004_bib0011","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2016.01.014","article-title":"Apatinib: a novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer","volume":"372","author":"Roviello","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2020.101004_bib0012","first-page":"991","article-title":"Serum alpha-fetoprotein in patients with neoplasms of the gastroin- testinal tract","volume":"35","author":"McIntire","year":"1975","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2020.101004_bib0013","first-page":"321","article-title":"Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers","volume":"87","author":"Chang","year":"1992","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tranon.2020.101004_bib0014","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1477-7819-11-246","article-title":"Characteristic analysis of \u03b1-fetoprotein-producing gastric carcinoma in China","volume":"11","author":"Li","year":"2013","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.tranon.2020.101004_bib0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00595-007-3501-0","article-title":"Alpha-fetoprotein-producing early gastric cancer of the remnant stomach: report of a case","volume":"37","author":"Shibata","year":"2007","journal-title":"Surg. Today"},{"key":"10.1016\/j.tranon.2020.101004_bib0016","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12029-013-9498-2","article-title":"Alpha-fetoproteinproducing nonmetastatic gastric adenocarcinoma: a rare entity","volume":"45","author":"Vivekanandarajah","year":"2014","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.tranon.2020.101004_bib0017","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0039-6060(03)00337-4","article-title":"Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion","volume":"134","author":"Talamonti","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.tranon.2020.101004_bib0018","doi-asserted-by":"crossref","first-page":"e3399","DOI":"10.1097\/MD.0000000000003399","article-title":"PRISMA-compliant article: clinical characteristics and factors influencing prognosis of patients with hepatoid adenocarcinoma of the stomach in China","volume":"95","author":"Qu","year":"2016","journal-title":"Medicine (Baltimore)."},{"issue":"2","key":"10.1016\/j.tranon.2020.101004_bib0019","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3892\/mco.2017.1288","article-title":"Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma","volume":"7","author":"Bozkaya","year":"2017","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.tranon.2020.101004_bib0020","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00595-007-3501-0","article-title":"Alphafetoprotein-producing early gastric cancer of the remnant stomach: report of a case","volume":"37","author":"Shibata","year":"2007","journal-title":"Surg. Today"},{"key":"10.1016\/j.tranon.2020.101004_bib0021","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/1097-0142(19930915)72:6<1827::AID-CNCR2820720606>3.0.CO;2-8","article-title":"Hepatoid adenocarcinoma of the stomach","volume":"72","author":"Nagai","year":"1993","journal-title":"CancerCancer"},{"issue":"1","key":"10.1016\/j.tranon.2020.101004_bib0022","article-title":"[A case of AFP-producing gastric cancer resected after efficient S-1\/CDDP combination chemotherapy]","volume":"38","author":"Yoshioka","year":"2011","journal-title":"Gan To Kagaku Ryoho"},{"issue":"2","key":"10.1016\/j.tranon.2020.101004_bib0023","first-page":"191e5","article-title":"[Retrospective analysis concerning AFP-producing gastric cancer]","volume":"40","author":"Fukuda","year":"2013","journal-title":"Gan To Kagaku Ryoho"},{"issue":"10","key":"10.1016\/j.tranon.2020.101004_bib0024","first-page":"1489e95","article-title":"A case of alpha-fetoprotein-producing gastric cancer with hepatic metastasis successfully treated with combination chemotherapy","volume":"105","author":"Kunoki","year":"2008","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"issue":"2","key":"10.1016\/j.tranon.2020.101004_bib0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3748\/wjg.v24.i2.266","article-title":"Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP","volume":"24","author":"Wang","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.tranon.2020.101004_bib0026","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-230X-11-56","article-title":"Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer","volume":"11","author":"Baek","year":"2011","journal-title":"BMC Gastroenterol."},{"issue":"2","key":"10.1016\/j.tranon.2020.101004_bib0027","doi-asserted-by":"crossref","first-page":"106e10","DOI":"10.2169\/internalmedicine.43.106","article-title":"Unresectable alpha fetoprotein-producing gastric cancer successfully treated with irinotecan and mitomycin C after S-1 failure","volume":"43","author":"Hirao","year":"2004","journal-title":"Intern. Med."},{"key":"10.1016\/j.tranon.2020.101004_bib0028","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.2147\/CMAR.S276969","article-title":"Effect of immune checkpoint inhibitors plus chemotherapy on advanced gastric cancer patients with elevated serum AFP or hepatoid adenocarcinoma","volume":"12","author":"Li","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.tranon.2020.101004_bib0029","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s00535-002-1099-y","article-title":"Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein","volume":"38","author":"Kamei","year":"2003","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.tranon.2020.101004_bib0030","first-page":"1823","article-title":"Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer","volume":"5","author":"Yonemura","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2020.101004_bib0031","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.3892\/ol.2017.6514","article-title":"Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha\u2011fetoprotein-producing gastric cancer: a case report","volume":"14","author":"Yasuhiro","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tranon.2020.101004_bib0032","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5230\/jgc.2013.13.1.58","article-title":"Five-year survival of alpha-fetoprotein-producing gastric cancer with synchronous liver metastasis: a case report","volume":"13","author":"Koneri","year":"2013","journal-title":"J. Gastric Cancer"},{"key":"10.1016\/j.tranon.2020.101004_bib0033","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3892\/ol.2015.3731","article-title":"Successful multimodal therapy for an \u03b1-fetoprotein-producing gastric cancer patient with simultaneous liver metastases","volume":"10","author":"Fang","year":"2015","journal-title":"Oncol. Lett."},{"issue":"13","key":"10.1016\/j.tranon.2020.101004_bib0034","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1200\/JCO.2015.63.5995","article-title":"Randomized, double-blind, placebo-controlled phase III trial of Apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction","volume":"34","author":"Li","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"26","key":"10.1016\/j.tranon.2020.101004_bib0035","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2013.48.8585","article-title":"Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial","volume":"31","author":"Li","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2020.101004_bib0036","doi-asserted-by":"crossref","first-page":"13208","DOI":"10.1038\/s41598-017-13192-8","article-title":"Efficacy and safety for Apatinib treatment in advanced gastric cancer: a real world study","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep."},{"issue":"37","key":"10.1016\/j.tranon.2020.101004_bib0037","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004610","article-title":"A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein","volume":"95","author":"Zhu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"14","key":"10.1016\/j.tranon.2020.101004_bib0038","doi-asserted-by":"crossref","first-page":"23817","DOI":"10.18632\/oncotarget.15909","article-title":"Clinicopathologic and prognostic characteristics of alpha-fetoprotein\u2013producing gastric cancer","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2020.101004_bib0039","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2014.11.018","article-title":"AFP (alpha fetoprotein): who are you in gastrology?","volume":"357","author":"Sun","year":"2015","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.tranon.2020.101004_bib0040","article-title":"The prognosis and clinicopathological characteristics of 70 gastric cancer patients with elevated serum AFP","volume":"39","author":"Yakun","year":"2017","journal-title":"Chin. J. Oncol."},{"key":"10.1016\/j.tranon.2020.101004_bib0041","first-page":"863","article-title":"Prognostic value of preoperative serum levels of five tumor markers (carcinoembryonic antigen, CA19-9, alpha-fetoprotein, CA72-4, and CA125) in gastric cancer","volume":"61","author":"Kim","year":"2014","journal-title":"Hepatogastroenterology"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523320304964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523320304964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:39:03Z","timestamp":1761835143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523320304964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1936523320304964"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2020.101004","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2020.101004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101004"}}